World Vaccine Congress Europe is Europe’s leading vaccine conference, bringing together researchers, manufacturers, policymakers, regulators, healthcare professionals, and industry leaders to advance vaccine innovation. The event covers the entire vaccine development lifecycle – from discovery and clinical research to manufacturing, regulation, global access, and pandemic preparedness – while fostering collaboration through networking, exhibitions, and scientific sessions.
The event consists of Pre-Congress Workshops, followed by the main Conference & Exhibition programme.
- Pre-Congress Workshops (19 October 2026) – dedicated deep-dive sessions focused on specific technical and scientific topics
- Conference & Exhibition (20–21 October 2026) – main programme featuring keynote sessions, scientific tracks, networking, partnering meetings, and exhibition showcases
Key Topics
The programme covers the full vaccine ecosystem, including:
- Vaccine Research & Development
- Clinical Trials & Clinical Development
- Vaccine Manufacturing & Bioprocessing
- Cancer Vaccines & Immunotherapy
- Emerging & Infectious Diseases
- Pandemic Preparedness
- Influenza & Respiratory Vaccines
- Global Health & Neglected Diseases
- Vaccine Technologies & Innovation
- Regulatory Affairs & Market Access
- Supply Chain & Logistics
- Antimicrobial Resistance (AMR)
- Veterinary Vaccines
- Partnerships, Funding & Collaboration